The Cushing’s disease group comprised 54 patients with Cushing’s disease (including 12 males; mean age 41 years; with 64.8% of this population with controlled arterial hypertension – mean blood ...

Blackberries, blueberries, cranberries, raspberries, and the like are tiny powerhouses of free radical-fighting antioxidants.

Patients with Cushing's disease treated with bilateral adrenalectomy are also at risk for Nelson's syndrome (corticotroph tumor progression) which occurs in up to 50% of the patients. [1, 11, 19 ...

Clinical features of Cushing's syndrome also improved. The most significant adverse event was hyperglycemia with HbA1c increasing from 5.8 ± 0.2 to 6.7 ± 0.3% (p < 0.01). [60] ...

More information: Max A. Thorwald et al. Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis, Alzheimer's & Dementia (2025).

Journal reference: Thorwald, M. A., et al. (2025) Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis.

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is as complex as its name is difficult to pronounce. It's sometimes referred to as simply "chronic fatigue," but this is just one of ...

AbbVie said its Phase 3 trial evaluating venetoclax in combination with azacitidine to treat higher-risk myelodysplastic syndrome didn't meet the primary endpoint of overall survival.

Once-daily osilodrostat administered in the evening is safe, effective, and restores circadian cortisol rhythms in patients with biochemically controlled Cushing syndrome (CS), according to results ...

The cuts slash the CDC's budget from nearly $9.2 billion in FY 2024 to $4.2 billion. At least 20%, or $1 billion, of the funding cut is moving to AHA. The cuts will have a trickle-down effect on ...

Longtime Los Angeles Times columnist Bill Plaschke revealed that he is battling Parkinson's disease. The 66-year-old Plaschke formally revealed the diagnosis in a Sunday column, where he said he's ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR ...